Citable filing context
FTV's research view summarizes recent SEC filing context, starting with earnings from Jul 29, 2026.
| Filed | Item | Context |
|---|---|---|
| Jul 29, 2026 | earnings | Fortive reported Q2 2026 revenue of $1.10 billion and raised its full-year 2026 adjusted EPS guidance. |
| Jun 11, 2026 | other | Fortive Corp shareholders elected eight directors and approved executive compensation and the auditor at the annual meeting. |
| May 14, 2026 | debt_offering | Fortive Corp issued $600 million of 4.750% notes due 2031 and $500 million of 5.250% notes due 2036. |
| Jul 29, 2026 | Guidance: adjusted_diluted_eps | 2.95 to 3.05 |
| Apr 30, 2026 | Guidance: adjusted_eps | 2.90 to 3.00 |
| Feb 4, 2026 | Guidance: adjusted_eps | 2.90 to 3.00 |
| Jul 29, 2026 | mda_quarterly | Fortive Corporation’s financial performance for the first half of 2026 reflects steady growth, with total revenue increasing 7.8% year-over-year to $2.17 billion. This growth was driven by a 6.1% increase in core revenue, supported by favorable pricing and volume gains in both the Intelligent Operating Solutions (IOS) and Advanced Healthcare Solutions (AHS) segments. Operating profit margins expanded to 18.5% from 16.7% in the prior-year period, benefiting from organizational streamlining, productivity gains via the Fortive Business System (FBS), and tariff refunds. The company maintains a robust liquidity position, supported by $374 million in cash and a $2.0 billion revolving credit facility. During the second quarter, Fortive successfully refinanced its debt profile by issuing $1.1 billion in senior unsecured notes due 2031 and 2036 to retire maturing 2026 notes. Capital allocation remains focused on growth and shareholder returns, evidenced by $58 million in bolt-on acquisitions for the AHS segment and the repurchase of 12.3 million shares for $700 million year-to-date. Key risks include ongoing geopolitical instability, inflationary pressures, and potential volatility in global trade policies. Management continues to leverage pricing and cost-mitigation strategies to navigate these macroeconomic headwinds while investing in innovation and commercial initiatives. |
| Apr 30, 2026 | mda_quarterly | Fortive Corporation reported first-quarter 2026 sales of $1.07 billion, representing 5.3% core revenue growth driven by 2.2% pricing and 3.1% volume increases. Following the June 2025 separation of Precision Technologies into Ralliant Corporation, the company now operates through two segments: Intelligent Operating Solutions (IOS) and Advanced Healthcare Solutions (AHS). IOS growth was fueled by demand for gas detection products and facilities and asset lifecycle software, while AHS growth was driven by sterilization products and dosimetry services, particularly in North America. Operating profit margins expanded 130 basis points to 17.9%, aided by organizational streamlining and Fortive Business System productivity measures. Financial risks include geopolitical instability in Ukraine and the Middle East, inflationary pressures, and potential U.S. government spending reductions under the One Big Beautiful Bill Act. The company is also monitoring the impact of the IEEPA Ruling on tariffs and the OECD Pillar Two initiative. Liquidity remains stable with $356 million in cash and a $2.0 billion revolving credit facility. Capital allocation focused heavily on shareholder returns, with $500 million spent on common stock repurchases and $18 million in dividends during the quarter, alongside the repayment of $292.9 million in Euro-denominated senior unsecured notes. |
Source: SEC EDGAR filing text and events; period Jul 29, 2026; filed Jul 29, 2026.
FTV company research is available with Aerarium Pro (CAD $10/mo). The five showcase tickers (TSLA, NVDA, AAPL, AMZN, PLTR) and the macro dashboard stay free. Already a subscriber? Sign in to pick up where you left off.